The Cannabis M&A Wave Is Here. Curaleaf Proved It. Here's Whether Green Thumb Should Ride It -- or Wait to Be Swept Up.

U.S. cannabis firm Curaleaf Holdings announced on August 18 an acquisition bid for Canadian retailer Aurora Cannabis, offering Aurora shareholders 0.3463 Curaleaf shares and $0.75 in cash per share, valued at approximately $260 million. The proposal caps at $5 per share should Curaleaf's stock exceed a certain level. Despite Aurora's financial struggles, including a $0.07 EPS loss in Q1 2027 and $93.7 million debt, the company's European market share appeals to Curaleaf, potentially expanding its global footprint and operational expertise.

The anticipated rescheduling of marijuana from Schedule I to Schedule III of the Controlled Substances Act could facilitate tax write-offs, making other M&A opportunities more appealing. Meanwhile, Green Thumb Industries, a U.S.-based cannabis retailer with over 140 stores in 14 markets, may capitalize on the rescheduling to acquire other companies, but its strategy will likely be selective and disciplined, targeting strategically valuable assets rather than large-scale mergers.